Cargando…
Factor inhibiting HIF (FIH-1) promotes renal cancer cell survival by protecting cells from HIF-1α-mediated apoptosis
BACKGROUND: Clear cell renal cell carcinoma (CCRCC) is the commonest form of kidney cancer. Up to 91% have biallelic inactivation of VHL, resulting in stabilisation of HIF-α subunits. Factor inhibiting HIF-1 is an enzyme that hydroxylates HIF-α subunits and prevents recruitment of the co-activator C...
Autores principales: | Khan, M N, Bhattacharyya, T, Andrikopoulos, P, Esteban, M A, Barod, R, Connor, T, Ashcroft, M, Maxwell, P H, Kiriakidis, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068507/ https://www.ncbi.nlm.nih.gov/pubmed/21386837 http://dx.doi.org/10.1038/bjc.2011.73 |
Ejemplares similares
-
HIF-1α determines the metastatic potential of gastric cancer cells
por: Rohwer, N, et al.
Publicado: (2009) -
HIF2α is involved in the expansion of CXCR4-positive cancer stem-like cells in renal cell carcinoma
por: Micucci, Carla, et al.
Publicado: (2015) -
Nuclear entry and export of FIH are mediated by HIF1α and exportin1, respectively
por: Wang, Yihua, et al.
Publicado: (2018) -
Hypoxia-associated markers in gastric carcinogenesis and HIF-2α in gastric and gastro-oesophageal cancer prognosis
por: Griffiths, E A, et al.
Publicado: (2008) -
The Role of Factor Inhibiting HIF (FIH-1) in Inhibiting HIF-1 Transcriptional Activity in Glioblastoma Multiforme
por: Wang, Enfeng, et al.
Publicado: (2014)